A Phase 1, Dose Escalation Study to Assess the Safety and Tolerability of ASP9853 With Either Docetaxel or Paclitaxel in Patients With Advanced Non-hematologic Malignancies

Clinical trial NCT01705483 · TERMINATED

Trial details

NCT number: NCT01705483
Sponsor: Astellas Pharma Global Development, Inc.
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Pharmacokinetics of ASP9853 Non-hematologic Malignancies

Start date: 2012-08-28
Primary completion: 2014-06-11
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.